Track topics on Twitter Track topics that are important to you
DelveInsight's Parkinson Disease Market Insights, Epidemiology and Market Forecast 2023 EU5 Reports provides an overview of the disease and global market size of the Parkinson Disease for the EU5. It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Parkinson Disease from 20102023. According to Publisher, the forecasted patient population of Parkinson Disease will increase at a CAGR of XX% from 2010 to 2023 and the worldwide Parkinson Disease market is estimated to be USD XX Million by 2023.
Parkinson's disease PD is a disorder caused by the malfunction and death of neurons. It is a chronic and progressive movement disorder which primarily affects neurons in substantia nigra area of the brain. Dopamine is usually responsible for the control and coordination process which is affected when the neuron malfunction and death occurs. As the disease progresses, the amount of dopamine produced in the brain decreases as a result the person is unable to control movement normally. This degenerative disorder affects the central nervous system.
Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs, its patent and exclusivity details.
The Report also covers the detailed global historical and forecasted epidemiological data covering EU5 from 20102023.
It also provides Market size of Parkinson disease for EU5 from 2010 and forecasted Market size to 2023.
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...